Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
about
Peripartum Cardiomyopathy in Intensive Care Unit: An UpdatePrinciples of the prolactin/vasoinhibin axisUse of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study.Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.Peripartum cardiomyopathy: A puzzle closer to solution.Peripartum cardiomyopathy: challenges in diagnosis and management.Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart.Peripartum cardiomyopathy: current management and future perspectivesRationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.Experiences of health care in women with Peripartum Cardiomyopathy in Sweden: a qualitative interview studyShared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.Molecular mechanisms of peripartum cardiomyopathy: A vascular/hormonal hypothesis.Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.Earlier detection can help avoid many serious complications of peripartum cardiomyopathy.Pregnancy, cardiomyopathies, and genetics.Pathophysiology and epidemiology of peripartum cardiomyopathy.An update on treatments and outcomes in peripartum cardiomyopathy.Improving outcomes in peripartum cardiomyopathy.Current applications of biomarkers in cardiomyopathies.Peripartum cardiomyopathy: current knowledge and future directions.Current knowledge and recent development on management of peripartum cardiomyopathy.Reducing the risks for relapse of heart failure in a subsequent pregnancy after peripartum cardiomyopathy?Value of the neutrophil-to-lymphocyte ratio in predicting left ventricular recovery in patients with peripartum cardiomyopathy.Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome.Management of pregnancy in cardiomyopathies and heart failure.Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.Safe and Effective Use of Pharmacologic and Device Therapy for Peripartum Cardiomyopathy.Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM.Peripartum cardiomyopathy: a systematic literature review.Mechanical circulatory support for patients with peripartum cardiomyopathy.Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres.In-hospital management and outcomes in patients with peripartum cardiomyopathy: a descriptive study using a national inpatient database in Japan.Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis.A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle-specific genes.Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy.Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
P2860
Q26774406-C4D11F38-161A-4E04-B432-338B1A821072Q26796671-D6CCA25D-8A85-4846-A11C-85A07A70F0A5Q27027354-53B0712B-0773-4B4E-BF9C-C2F9D517ADF0Q30372111-B0C9CD8E-9ACD-4801-A0BE-3D1A74C51C3EQ33164921-306D7485-A062-484D-A08B-DCEA3F7A5B7BQ33358118-490759C5-C899-4470-B30E-4539B21DBEF5Q33363307-4F8CF7B8-BAF9-40FB-A9C1-8450A68CFBEAQ33623465-3F4D1CB7-937D-42B0-90B2-AA78A8348462Q34969073-1EA255F9-1679-4932-B6F1-BDB1AB90948DQ35578643-55D1E385-1AF2-4B0B-AF14-4B1B8842A950Q36214915-912C0F4A-84EC-48E3-9730-CEA79A89C132Q36216468-D1A45773-391D-4EA0-B354-16484280051DQ36701193-F719DDE1-E578-4E4A-817E-5C7173AD72FDQ36701224-A2B64A4A-2833-4917-B626-75E7305FF84CQ36853140-B2B3DDA9-B4CD-4826-A688-ABD66C8232ABQ37738585-64B3937E-C4D3-4604-9D71-42452FCDA56EQ38158206-04930892-C657-452F-9277-0953755C646BQ38180838-3963041D-90B2-4441-A06A-186A74B76E12Q38200908-1BCC1B3C-6581-4B02-ABCB-CFAAF383B9CBQ38224408-FA9BC8BD-DBAC-489D-8756-48F03E631638Q38451142-44EA063A-F989-4767-861D-14053480078AQ38536678-E219A80E-10DB-486B-A63F-6BA2044E49E6Q38561417-AEA4D7FC-6599-42F6-BA82-A9B091AAF800Q38609304-B3BAC724-BC99-4187-BF22-7C4A21069CC7Q38670300-4B6246D1-6A7A-42B9-99F4-72D3279986B8Q38681644-E907DA66-57D6-4C29-ACC4-6CBCFF62D190Q38734824-1326AF89-64B8-4CA7-8191-13F975BDA943Q38780993-BD8CC8D0-2970-469C-878B-B73B7FAF422FQ38875036-87CE7135-139C-4DAB-AD1D-9B8AF273D284Q38884855-F3489DF1-8406-4A66-BBAD-71F369D53EE3Q38921705-BFAB0B6C-0AD6-47D7-9994-199353D44FDBQ38933053-2B453B51-FBEB-466D-AFAB-3541BCBE4B4AQ39898330-05CFD25B-9848-4822-8F96-007D199B4837Q40083768-D39DA063-8C1E-4F64-BE99-4097EBDACCFDQ40320945-694C3C78-71B1-437F-896C-30C726A6D600Q41140696-79070983-A2C6-481B-AD83-0FDC8F6D8F68Q41330928-7A31331A-C034-4418-9634-0BA85625DC73Q41465237-A8A911F8-B665-4A7F-BDA7-796E2234A1AAQ41613457-3FB6AF05-4DAA-48B1-AA79-876B8BAE991CQ42513803-C52D2FBD-0730-4668-BF52-2A6A657EA338
P2860
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phenotyping and outcome on con ...... with peripartum cardiomyopathy
@en
Phenotyping and outcome on con ...... ith peripartum cardiomyopathy.
@nl
type
label
Phenotyping and outcome on con ...... with peripartum cardiomyopathy
@en
Phenotyping and outcome on con ...... ith peripartum cardiomyopathy.
@nl
prefLabel
Phenotyping and outcome on con ...... with peripartum cardiomyopathy
@en
Phenotyping and outcome on con ...... ith peripartum cardiomyopathy.
@nl
P2093
P2860
P1476
Phenotyping and outcome on con ...... with peripartum cardiomyopathy
@en
P2093
A Haghikia
C S von Kaisenberg
E Libhaber
E Podewski
J Bauersachs
P2860
P2888
P356
10.1007/S00395-013-0366-9
P577
2013-06-28T00:00:00Z